NASDAQ:CASI
$2.75
(
8.27%
)
Friday, 26th May 2023
CASI Pharmaceuticals Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.04 | $3.22 | Friday, 26th May 2023 CASI stock ended at $2.75. This is 8.27% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 12.54% from a day low at $2.52 to a day high of $2.84. |
| 90 days | $1.60 | $3.70 | |
| 52 weeks | $0.335 | $4.86 |
Historical CASI Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $2.68 | $2.84 | $2.52 | $2.75 | 20 675 |
| 2023-05-25 | $2.34 | $2.63 | $2.30 | $2.54 | 22 204 |
| 2023-05-24 | $2.11 | $2.39 | $2.05 | $2.27 | 21 804 |
| 2023-05-23 | $2.04 | $2.40 | $2.04 | $2.05 | 58 425 |
| 2023-05-22 | $2.22 | $2.22 | $2.04 | $2.05 | 19 450 |
| 2023-05-19 | $2.24 | $2.34 | $2.22 | $2.22 | 5 187 |
| 2023-05-18 | $2.22 | $2.28 | $2.10 | $2.20 | 9 044 |
| 2023-05-17 | $2.40 | $2.60 | $2.28 | $2.31 | 8 905 |
| 2023-05-16 | $2.68 | $2.68 | $2.48 | $2.50 | 4 913 |
| 2023-05-15 | $2.62 | $2.62 | $2.38 | $2.53 | 43 835 |
| 2023-05-12 | $2.53 | $2.57 | $2.52 | $2.52 | 5 546 |
| 2023-05-11 | $2.56 | $2.57 | $2.51 | $2.51 | 2 311 |
| 2023-05-10 | $2.54 | $2.73 | $2.54 | $2.60 | 3 296 |
| 2023-05-09 | $2.51 | $2.61 | $2.50 | $2.58 | 7 741 |
| 2023-05-08 | $2.53 | $2.64 | $2.50 | $2.50 | 9 397 |
| 2023-05-05 | $2.86 | $2.86 | $2.57 | $2.57 | 12 786 |
| 2023-05-04 | $2.92 | $2.92 | $2.70 | $2.88 | 5 524 |
| 2023-05-03 | $2.64 | $2.80 | $2.64 | $2.72 | 11 110 |
| 2023-05-02 | $2.72 | $2.81 | $2.60 | $2.65 | 24 487 |
| 2023-05-01 | $2.71 | $2.78 | $2.69 | $2.69 | 24 648 |
| 2023-04-28 | $2.89 | $2.90 | $2.81 | $2.86 | 3 993 |
| 2023-04-27 | $2.84 | $3.06 | $2.82 | $2.95 | 8 398 |
| 2023-04-26 | $3.02 | $3.22 | $2.84 | $2.84 | 6 587 |
| 2023-04-25 | $3.04 | $3.04 | $2.97 | $2.97 | 22 796 |
| 2023-04-24 | $2.99 | $3.09 | $2.86 | $3.04 | 10 737 |
| 2023-04-21 | $2.98 | $3.14 | $2.98 | $3.01 | 11 364 |
| 2023-04-20 | $3.00 | $3.07 | $3.00 | $3.03 | 4 099 |
| 2023-04-19 | $3.15 | $3.15 | $3.02 | $3.09 | 8 437 |
| 2023-04-18 | $3.23 | $3.25 | $3.02 | $3.21 | 14 281 |
| 2023-04-17 | $3.59 | $3.59 | $3.26 | $3.30 | 33 136 |
| 2023-04-14 | $3.00 | $3.66 | $2.88 | $3.59 | 92 410 |
| 2023-04-13 | $2.78 | $3.09 | $2.74 | $2.94 | 41 980 |
| 2023-04-12 | $2.88 | $2.88 | $2.64 | $2.77 | 23 177 |
| 2023-04-11 | $3.16 | $3.16 | $2.51 | $2.80 | 75 275 |
| 2023-04-10 | $3.65 | $3.65 | $3.12 | $3.17 | 82 148 |
| 2023-04-06 | $3.62 | $3.70 | $3.35 | $3.70 | 110 692 |
| 2023-04-05 | $3.14 | $3.70 | $3.10 | $3.40 | 101 148 |
| 2023-04-04 | $2.66 | $3.21 | $2.66 | $3.15 | 182 198 |
| 2023-04-03 | $2.40 | $2.79 | $2.25 | $2.64 | 73 092 |
| 2023-03-31 | $2.02 | $2.35 | $1.95 | $2.32 | 30 352 |
| 2023-03-30 | $1.95 | $2.10 | $1.91 | $2.07 | 38 836 |
| 2023-03-29 | $2.02 | $2.10 | $1.89 | $1.98 | 640 484 |
| 2023-03-28 | $1.82 | $2.00 | $1.71 | $1.99 | 42 666 |
| 2023-03-27 | $1.68 | $1.87 | $1.68 | $1.82 | 5 643 |
| 2023-03-24 | $1.66 | $1.69 | $1.60 | $1.64 | 3 597 |
| 2023-03-23 | $1.79 | $1.92 | $1.65 | $1.73 | 42 055 |
| 2023-03-22 | $1.67 | $1.80 | $1.63 | $1.79 | 26 346 |
| 2023-03-21 | $1.65 | $1.67 | $1.63 | $1.63 | 5 386 |
| 2023-03-20 | $1.68 | $1.71 | $1.63 | $1.63 | 9 832 |
| 2023-03-17 | $1.75 | $1.83 | $1.67 | $1.68 | 9 990 |
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
